Wordt geladen...

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

BACKGROUND: Current pharmacological therapies for COPD improve quality of life and symptoms and reduce exacerbations. Given the progressive nature of COPD, it is arguably more important to understand whether the available therapies are able to delay clinical deterioration; the concept of “clinically...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Chron Obstruct Pulmon Dis
Hoofdauteurs: Singh, Dave, Fabbri, Leonardo M, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2019
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400232/
https://ncbi.nlm.nih.gov/pubmed/30880943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S196383
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!